Good mass spectrometry and its place in good science

Liquid Chromatographic Determination of the Cyanobacterial Toxin β-N-Methylamino-L-Alanine in Algae Food Supplements, Freshwater Fish, and Bottled Water

(2016) PETER M. SCOTT et al.   JOURNAL OF FOOD PROTECTION

An Appeal to Medical Journal Editors: The Need for a Full Description of Laboratory Methods and Specimen Handling in Clinical Study Reports

(2012) N. Rifai et al.   CLINICAL CHEMISTRY

Endogenous morphine-like compound immunoreactivity increases in parkinsonism

(2011) G. Charron et al.   BRAIN

Mapping of endogenous morphine-like compounds in the adult mouse brain: Evidence of their localization in astrocytes and GABAergic cells

(2011) Alexis Laux et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Bring on the biomarkers

(2011) George Poste   NATURE

Analytical methods for 3-nitrotyrosine quantification in biological samples: the unique role of tandem mass spectrometry

(2010) Dimitrios Tsikas   AMINO ACIDS

Cyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food webs

(2010) Larry E. Brand et al.   HARMFUL ALGAE

Protein PTMs: post-translational modifications or pesky trouble makers?

(2010) Ralph A. Bradshaw et al.   JOURNAL OF MASS SPECTROMETRY

The pros and cons of peptide-centric proteomics

(2010) Mark W Duncan et al.   NATURE BIOTECHNOLOGY

Endogenous Morphine Levels Are Increased in Sepsis: A Partial Implication of Neutrophils

(2010) Elise Glattard et al.   PLoS One

Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure

(2010) S. Jonasson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease

(2009) J. Pablo et al.   ACTA NEUROLOGICA SCANDINAVICA

Determination of the neurotoxins BMAA (β-N-methylamino-L-alanine) and DAB (α-,γ-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms

(2009) Elisabeth J. Faassen et al.   Amyotrophic Lateral Sclerosis

Consumption offa cai Nostocsoup: A Potential for BMAA exposure fromNostoccyanobacteria in China?

(2009) Britton R. Roney et al.   Amyotrophic Lateral Sclerosis

Cyanobacteria and BMAA exposure from desert dust: A possible link to sporadic ALS among Gulf War veterans

(2009) Paul Alan Cox et al.   Amyotrophic Lateral Sclerosis

Cyanobacteria and BMAA: Possible linkage with avian vacuolar myelinopathy (AVM) in the south-eastern United States

(2009) Robert R. Bidigare et al.   Amyotrophic Lateral Sclerosis

Presence of the neurotoxic amino acids β-N-methylamino-L-alanine (BMAA) and 2,4-diamino-butyric acid (DAB) in shallow springs from the Gobi Desert

(2009) Derek Craighead et al.   Amyotrophic Lateral Sclerosis

Previous studies underestimate BMAA concentrations in cycad flour

(2009) Ran Cheng et al.   Amyotrophic Lateral Sclerosis

A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms

(2009) Tracie A. Caller et al.   Amyotrophic Lateral Sclerosis

Analytical protocol for identification of BMAA and DAB in biological samples

(2009) Zdeněk Spáčil et al.   ANALYST

Comparative Aspects of Endogenous Morphine Synthesis and Signaling in Animals

(2009) Wei Zhu et al.   Annals of the New York Academy of Sciences

New Procedure for the Determination of 3-Nitrotyrosine in Plasma by GC–ECD

(2009) Radmila Pavlovic et al.   CHROMATOGRAPHIA

S-Nitrosothiols in Blood: Does Photosensitivity Explain a 4-Order-of-Magnitude Concentration Range?

(2009) R. Rossi et al.   CLINICAL CHEMISTRY

Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept

(2009) A. Bouabidi et al.   JOURNAL OF CHROMATOGRAPHY A

Nitro-fatty Acids Occur in Human Plasma in the Picomolar Range: a Targeted Nitro-lipidomics GC–MS/MS Study

(2009) Dimitrios Tsikas et al.   LIPIDS

A HUPO test sample study reveals common problems in mass spectrometry–based proteomics

(2009) Alexander W Bell et al.   NATURE METHODS

Parkinson–dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue

(2009) Laura R. Snyder et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

LC–MS/MS determination of the isomeric neurotoxins BMAA (β-N-methylamino-l-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius

(2009) Thomas Krüger et al.   TOXICON

Determination of the neurotoxin BMAA (β-N-methylamino-l-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry)

(2008) Johan Rosén et al.   ANALYST

β-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates

(2008) M. Esterhuizen et al.   ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

Co-occurrence of β-N-methylamino-l-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990–2004

(2008) James S. Metcalf et al.   ENVIRONMENTAL MICROBIOLOGY

Key aspects of analytical method validation and linearity evaluation

(2008) Pedro Araujo   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA

(2008) Holly E. Johnson et al.   JOURNAL OF ETHNOPHARMACOLOGY

Dopamine is necessary to endogenous morphine formation in mammalian brainin vivo

(2008) Carla Neri et al.   JOURNAL OF NEUROCHEMISTRY

Iodoacetamide-induced artifact mimics ubiquitination in mass spectrometry

(2008) Michael L Nielsen et al.   NATURE METHODS

Effective determination method for a cyanobacterial neurotoxin, β-N-methylamino-l-alanine

(2008) Takuya Kubo et al.   TOXICON

Identification and confirmation of chemical residues in food by chromatography-mass spectrometry and other techniques

(2008) Steven J. Lehotay et al.   TRAC-TRENDS IN ANALYTICAL CHEMISTRY